News

Biotech crops may finally be breaking through to the commercial mainstream in Europe, with a 77 perc ent increase in planting between 2006 and 2007, according to data released this week.

Imperial Innovations Group is stepping up the pace of its technology commercialisation drive with a £30 million placing with existing investors.

Consumer products giant Procter and Gamble is applying its knowledge of consumers to the development of new medicines – and wants to share its insights with biotech companies.